LXEO Lexeo Therapeutics, Inc.
$2.87
Lexeo Therapeutics, Inc. (LXEO) Earnings News
Earnings press releases, previews and reviews for Lexeo Therapeutics, Inc. (LXEO), newest first.
Monday
November 16, 2026
7:00 AM ET
Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Reports Third Quarter 2026 Financial Results
Sunday
November 15, 2026
7:00 AM ET
Lexeo Therapeutics to Report Third Quarter 2026 Financial Results and Provide LX2020 Business Update on November 16, 2026
Wednesday
August 12, 2026
7:00 AM ET
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights